Jul 31, 2023

Brady Q4 2023 Earnings Report

Reported record EPS for Q4 2023, expanded share buyback program, and announced fiscal 2024 EPS guidance.

Key Takeaways

Brady Corporation reported a 6.8% increase in sales and a record EPS of $1.00 for the fourth quarter of fiscal year 2023. Organic sales increased by 6.9%. The company also expanded its share buyback program by $100 million and provided EPS guidance for fiscal year 2024.

Sales for the quarter increased 6.8 percent, with organic sales up by 6.9 percent.

Diluted EPS reached an all-time high of $1.00, a 23.5 percent increase year-over-year.

The company returned $56.4 million to shareholders through dividends and share repurchases during the quarter.

An additional $100 million was authorized for share repurchases.

Total Revenue
$346M
Previous year: $324M
+6.8%
EPS
$1.04
Previous year: $0.87
+19.5%
Organic Sales Growth
6.9%
Previous year: 9%
-23.3%
Gross Profit
$176M
Previous year: $163M
+7.8%
Cash and Equivalents
$152M
Previous year: $114M
+32.8%
Total Assets
$1.39B
Previous year: $1.37B
+1.6%

Brady

Brady

Forward Guidance

Brady expects GAAP earnings per diluted Class A Nonvoting Common Share to range from $3.70 to $3.95, and Diluted EPS Excluding Certain Items* to range from $3.85 to $4.10 for the year ending July 31, 2024.

Positive Outlook

  • GAAP earnings per diluted Class A Nonvoting Common Share to range from $3.70 to $3.95
  • Increase of 5.4 percent to 12.5 percent over the GAAP earnings per diluted Class A nonvoting Common Share of $3.51 for the year ended July 31, 2023
  • Diluted EPS Excluding Certain Items* to range from $3.85 to $4.10 for the year ending July 31, 2024
  • Increase of 5.8 percent to 12.6 percent over Diluted EPS Excluding Certain Items* of $3.64 for the year ended July 31, 2023
  • Full-year income tax rate of approximately 22 percent

Challenges Ahead

  • Amortization expense equating to $0.15 per share for the year ending July 31, 2024.
  • Capital expenditures are expected to approximate $75 million, which is inclusive of facility construction costs of approximately $55 million.
  • Guidance is based on foreign currency exchange rates as of July 31, 2023.
  • Guidance assumes continued economic growth.
  • Depreciation and amortization expense ranging from $32 million to $34 million.